SII, Bharat Biotech Welcome Enhanced Focus on Health, Immunisation in Budget
FOLLOW US ON:
Leading vaccine manufacturers Serum Institute of India and Bharat Biotech on Monday applauded the government s increased allocation for the healthcare sector and on providing Rs 35,000 crore towards COVID-19 vaccination in 2021-22 fiscal. I have provided Rs 35,000 crore for COVID-19 vaccine in this year 2021-22. I m committed to provide further funds if required. The Budget outlay for health and well being is Rs 2.23 lakh crore in 2021-22 as against BE of Rs 94,452 crore and marks an increase of 137 per cent, she said while presenting 2021-22 Budget in the Lok Sabha.
Monday described as far reaching initiative the allocation of Rs 35,000 crore for COVID-19 vaccination in the Union Budget and said it would help the country become free of the viral disease. Dr. Reddys Laboratories Ltd said the budget was growth- oriented with a lot of positive interventions and with something in it for everyone . Welcoming the proposal for Rs 35,000 crore outlay for COVID-19 vaccines, city-based Bharat Biotech Chairman and Managing Director Krishna Ella said Its a great step ahead, and far-reaching budget announcement., providing Rs 35,000 crore for COVID-19 vaccination in 2021-22. The Finance Minister s commitment providing more funds in order to contain the coronavirus pandemic and provide an effective, smooth path for the vaccination scheme will help contain, and lead our nation towards accomplishing a COVID-19 disease free Bharat, he said in statement here.
Leading vaccine manufacturers Serum Institute of India and Bharat Biotech on Monday applauded the government s increased allocation for the healthcare sector and on providing Rs 35,000 crore towards COVID-19 vaccination in 2021-22 fiscal. I have provided Rs 35,000 crore for COVID-19 vaccine in this year 2021-22. I m committed to provide further funds if required. The Budget outlay for health and well being is Rs 2.23 lakh crore in 2021-22 as against BE of Rs 94,452 crore and marks an increase of 137 per cent, she said while presenting 2021-22 Budget in the Lok Sabha. Commenting on the budget announcements, Serum Institute of India CEO Adar Poonawalla said that globally, spending on healthcare infrastructure and vaccines have given countries and their economies the best bang for their buck.
Union Budget 2021: Bharat Biotech, Serum Institute of India laud higher allocation for healthcare sector SII CEO Adar Poonawalla said that globally, spending on healthcare infrastructure and vaccines has given countries and their economies the best chance at fighting COVID-19 Representational image. PTI
New Delhi: Leading vaccine manufacturers Serum Institute of India and Bharat Biotech on Monday applauded the government s increased allocation for the healthcare sector and on providing Rs 35,000 crore towards COVID-19 vaccination in 2021-22 fiscal. I have provided Rs 35,000 crore for COVID-19 vaccine in this year 2021-22. I m committed to provide further funds if required. The Budget outlay for health and well being is Rs 2.23 lakh crore in 2021-22 as against BE of Rs 94,452 crore and marks an increase of 137 percent, she said while presenting 2021-22 Budget in the Lok Sabha.
Bharat Biotech, Precisa Medicamentos ink deal for Covaxin supply to Brazil medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.